ScholarIQanswers from OpenAlex

Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone

PaperCitations, authors & open-access status

Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone have?

ScholarIQcitation count

Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone has 62 citations in the OpenAlex counts ScholarIQ stores.

When was Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone published?

ScholarIQyear

Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone has 2006 year in the ScholarIQ index.

What is the open-access status of Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone?

ScholarIQoa status

Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone has closed oa status in the ScholarIQ index.

What is the DOI of Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone?

ScholarIQdoi

The DOI for Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone is on the source record.

What is the PMID of Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone?

ScholarIQpmid

The PMID for Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone is on the source record.

What is the OpenAlex record for Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone?

ScholarIQopenalex

The OpenAlex for Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial